Progenics Pharmaceuticals, Inc. (PGNX) announced today its offer to acquire EXINI Diagnostics AB (publ), a leader in the development software solutions for medical decision support based on advanced image analysis, through a public offer to the shareholders of EXINI (the “Offer”).
Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,150,517, entitled “Bendamustine Derivatives and Methods of Using Same.”
Concert Pharmaceuticals, Inc. (CNCE) today presented results from a Phase 1 single ascending dose trial of CTP-656, a next generation potentiator being developed for the treatment of cystic fibrosis.
Applied Optoelectronics to Announce Third Quarter 2015 Financial Results on November 5, 2015
Chinese stocks rose, sending the benchmark index to the highest level in two months, after economic data showed faster growth in the services sector and margin debt posted its longest stretch of gains since August.
Investors who think the stock market is heading lower probably shouldn't be buying technology stocks since they usually do poorly in a risk-off environment and are more volatile than most other sectors.
Emerging markets aren't just suffering through another market rout—it's a third wave of the global financial crisis, Goldman Sachs said.
The “darlings” of mutual funds and institutional funds is a popularity contest tracked by Credit Suisse that might be almost used as a contrarian indicator, in a note titled The Darlings of Active Managers The Most Crowded Names in US Small, Mid & Large Cap Funds .
Former IMF chief Dominique Strauss-Kahn is to pursue damages following allegations of “fraud” and “misuse of company assets” at the now-defunct investment firm Leyne Strauss-Kahn Partners (LSK), his lawyer Jean Veil told reporters on Saturday.